In this open-label, proof-of-concept study in Brazil, bedaquiline showed substantial antimicrobial activity against Mycobacterium leprae in nine patients.
The New England Journal of Medicine: Search Results in Infectious Disease
Bedaquiline Monotherapy for Multibacillary Leprosy
